QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 |
(State or other jurisdiction of incorporation or organization) |
(I.R.S. Employer Identification No.) |
Title of each class |
Trading Symbols |
Name of each exchange on which registered | ||
one-fourth of one redeemable warrant |
||||
Large accelerated filer | ☐ | Accelerated filer | ☐ | |||
Non-accelerated filer |
☒ | Smaller reporting company | ||||
Emerging growth company |
(1) | In September 2021, the registrant became a fully remote company. Accordingly, it does not maintain a principal executive office. |
Page |
||||
Part I. Financial Information | 1 | |||
1 | ||||
1 | ||||
2 | ||||
3 | ||||
4 | ||||
5 | ||||
18 | ||||
21 | ||||
21 | ||||
Part II. Other Information | 22 | |||
22 | ||||
22 | ||||
22 | ||||
22 | ||||
22 | ||||
22 | ||||
23 | ||||
Part III. Signatures | 24 |
March 31, 2022 |
December 31, 2021 |
|||||||
(Unaudited) |
||||||||
ASSETS |
||||||||
Current assets |
||||||||
Cash |
$ | $ | ||||||
Prepaid expenses |
||||||||
|
|
|
|
|||||
Total Current Assets |
||||||||
Forward purchase agreement derivative asset |
||||||||
Marketable securities held in Trust Account |
||||||||
|
|
|
|
|||||
TOTAL ASSETS |
$ |
$ |
||||||
|
|
|
|
|||||
LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT |
||||||||
Current liabilities |
||||||||
Accrued expenses |
$ | $ | ||||||
Accrued offering costs |
||||||||
Due to related party |
||||||||
|
|
|
|
|||||
Total Current Liabilities |
||||||||
Warrant liabilities |
||||||||
Deferred underwriting fee payable |
||||||||
|
|
|
|
|||||
Total Liabilities |
||||||||
|
|
|
|
|||||
Commitments and Contingencies |
||||||||
Class A common stock subject to possible redemption, $ shares at $per share redemption value March 31, 2022 and December 31, 2021 |
||||||||
Stockholders’ Deficit |
||||||||
Preferred stock, $ |
||||||||
Class A common stock, $ |
||||||||
Class B common stock, $ |
||||||||
Additional paid-in capital |
||||||||
Accumulated deficit |
( |
) | ( |
) | ||||
|
|
|
|
|||||
Total Stockholders’ Deficit |
( |
) |
( |
) | ||||
|
|
|
|
|||||
TOTAL LIABILITIES, CLASS A COMMON STOCK SUBJECT TO POSSIBLE REDEMPTION AND STOCKHOLDERS’ DEFICIT |
$ |
$ |
||||||
|
|
|
|
Three Months Ended March 31, |
||||||||
2022 |
2021 |
|||||||
Formation and operating costs |
$ | $ | ||||||
|
|
|
|
|||||
Loss from operations |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Other income: |
||||||||
Change in fair value of warrant liabilities and forward purchase agreement derivative asset |
||||||||
Interest earned on marketable securities held in Trust Account |
||||||||
|
|
|
|
|||||
Total other income |
||||||||
|
|
|
|
|||||
Net income |
$ |
$ |
||||||
|
|
|
|
|||||
Weighted average shares outstanding, Class A common stock |
||||||||
|
|
|
|
|||||
Basic and diluted net income per share, Class A common stock |
$ |
$ |
||||||
|
|
|
|
|||||
Weighted average shares outstanding, Class B common stock |
||||||||
|
|
|
|
|||||
Basic net income per share, Class B common stock |
$ |
$ |
||||||
|
|
|
|
|||||
Weighted average shares outstanding, Class B common stock |
||||||||
|
|
|
|
|||||
Diluted net income per share, Class B common stock |
$ |
$ |
||||||
|
|
|
|
Class A Common Stock |
Class B Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Deficit |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance — January 1, 2022 |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
Net income |
— |
— |
— |
— |
— |
|||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – March 31, 2022 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Class A Common Stock |
Class B Common Stock |
Additional Paid-in Capital |
Accumulated Deficit |
Total Stockholders’ Equity (Deficit) |
||||||||||||||||||||||||
Shares |
Amount |
Shares |
Amount |
|||||||||||||||||||||||||
Balance — January 1, 2021 |
$ |
$ |
$ |
$ |
( |
) |
$ |
|||||||||||||||||||||
Excess of proceeds from the sale of Private Placement Warrants to Sponsor |
— | — | — | — | — | |||||||||||||||||||||||
Forfeiture of Founder Shares |
— | — | ( |
) | ( |
) | — | — | ||||||||||||||||||||
Accretion for Class A common stock to redemption value |
— | — | ( |
) | ( |
) | ( |
) | ||||||||||||||||||||
Net income |
— | — | — | — | — | |||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||
Balance – March 31, 2021 (unaudited) |
$ |
$ |
$ |
$ |
( |
) |
$ |
( |
) | |||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2022 |
Three Months Ended March 31, 2021 |
|||||||
Cash Flows from Operating Activities: |
||||||||
Net income |
$ | $ | ||||||
Adjustments to reconcile net income to net cash used in operating activities: |
||||||||
Operating costs paid by Sponsor |
— | |||||||
Operating costs paid through promissory note |
— | |||||||
Change in fair value of warrant liabilities and forward purchase agreement derivative asset |
( |
) | ( |
) | ||||
Transaction costs incurred in connection with warrant liabilities |
— | |||||||
Interest earned on marketable securities held in Trust Account |
( |
) | ( |
) | ||||
Changes in operating assets and liabilities: |
||||||||
Prepaid expenses |
( |
) | ( |
) | ||||
Due to related party |
— | |||||||
Accrued expenses |
||||||||
|
|
|
|
|||||
Net cash used in operating activities |
( |
) |
( |
) | ||||
|
|
|
|
|||||
Cash Flows from Investing Activities: |
||||||||
Investment of cash in Trust Account |
— | ( |
) | |||||
|
|
|
|
|||||
Net cash used in investing activities |
— |
( |
) | |||||
|
|
|
|
|||||
Cash Flows from Financing Activities |
||||||||
Proceeds from sale of Units, net of underwriting discounts paid |
— | |||||||
Proceeds from sale of Private Placements Warrants |
— | |||||||
Due from Sponsor |
— | ( |
) | |||||
Repayment of promissory note—related party |
— | ( |
) | |||||
Payment of offering costs |
— | ( |
) | |||||
|
|
|
|
|||||
Net cash provided by financing activities |
— |
|||||||
|
|
|
|
|||||
Net Change in Cash |
( |
) |
||||||
Cash – Beginning of period |
||||||||
|
|
|
|
|||||
Cash – End of period |
$ |
$ |
||||||
|
|
|
|
|||||
Non-Cash investing and financing activities: |
||||||||
Offering costs included in accrued offering costs |
$ | — | $ | ( |
) | |||
|
|
|
|
|||||
Offering costs paid through promissory note |
$ | — | $ | |||||
|
|
|
|
|||||
Payment of prepaid expenses through promissory note |
$ | — | $ | |||||
|
|
|
|
|||||
Accretion for Class A common stock to redemption amount |
$ | — | $ | |||||
|
|
|
|
|||||
Deferred underwriting fee payable |
$ | — | $ | |||||
|
|
|
|
Gross proceeds |
$ | |||
Less: |
||||
Proceeds allocated to Public Warrants |
( |
) | ||
Class A common stock issuance costs |
( |
) | ||
Plus: |
||||
Accretion of carrying value to redemption value |
||||
Class A common stock subject to possible redemption |
$ | |||
Three Months Ended March 31, 2022 |
Three Months Ended March 31, 2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Basic net income per common share |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income, as adjusted |
$ | $ | $ | $ | ||||||||||||
Denominator: |
||||||||||||||||
Basic weighted average shares outstanding |
||||||||||||||||
Basic net income per common share |
$ | $ | $ | $ |
Three Months Ended March 31, 2022 |
Three Months Ended March 31, 2021 |
|||||||||||||||
Class A |
Class B |
Class A |
Class B |
|||||||||||||
Diluted net income per common share |
||||||||||||||||
Numerator: |
||||||||||||||||
Allocation of net income, as adjusted |
$ | $ | $ | $ | ||||||||||||
Denominator: |
||||||||||||||||
Diluted weighted average shares outstanding |
||||||||||||||||
Diluted net income per common share |
$ | $ | $ | $ |
• | in whole and not in part; |
• | at a price of $ |
• | upon not less than |
• | if, and only if, the closing price of the Class A common stock equals or exceeds $ a period ending three business days before the Company sends the notice of redemption to the warrant holders. |
Level 1: | Quoted prices in active markets for identical assets or liabilities. An active market for an asset or liability is a market in which transactions for the asset or liability occur with sufficient frequency and volume to provide pricing information on an ongoing basis. |
Level 2: | Observable inputs other than Level 1 inputs. Examples of Level 2 inputs include quoted prices in active markets for similar assets or liabilities and quoted prices for identical assets or liabilities in markets that are not active. |
Level 3: | Unobservable inputs based on our assessment of the assumptions that market participants would use in pricing the asset or liability. |
Held-To-Maturity |
Level |
Amortized Cost |
Gross Holding Loss |
Fair Value |
||||||||||||||
Assets: |
||||||||||||||||||
March 31, 2022 |
U.S. Treasury Securities (Mature on 6/16/2022) | 1 | |
$ |
|
|
|
$ |
( |
) |
|
$ | ||||||
March 31, 2022 |
FPA Derivativ e Asset |
3 | |
|
|
|
|
|
|
|
$ | |||||||
December 31, 2021 |
Marketable Securities held in Trust Account –Treasury Trust Money Market Fund | 1 | |
|
|
|
|
|
|
|
$ | |||||||
December 31, 2021 |
FPA Derivative Asset | 3 | |
|
|
|
|
|
|
|
$ | |||||||
Liabilities: |
|
|
|
|
|
|
|
|
||||||||||
March 31, 2022 |
Warrant Liability – Public Warrants | 1 | |
|
|
|
|
|
|
|
$ | |||||||
March 31, 2022 |
Warrant Liability – Private Placement Warrants | 2 | |
|
|
|
|
|
|
|
$ | |||||||
December 31, 2021 |
Warrant Liability – Public Warrants | 1 | |
|
|
|
|
|
|
|
$ | |||||||
December 31, 2021 |
Warrant Liability – Private Placement Warrants | 2 | |
|
|
|
|
|
|
|
$ |
March 31, 2022 |
December 31, 2021 |
|||||||
Forward Purchase Price (per unit) |
$ | $ | ||||||
Underlying Asset Price (per share) |
$ | $ | ||||||
Number of Warrants per unit |
||||||||
Concluded Unit Value |
||||||||
Time to Maturity (Years) |
||||||||
Risk Free Rate |
% | % |
Private Placement |
Public |
Warrant Liabilities |
||||||||||
Fair value as of January 1, 202 2 |
$ | $ | $ | |||||||||
Change in fair value |
||||||||||||
Fair value as of March 31, 2022 |
$ | $ | $ | |||||||||
Private Placement |
Public |
Warrant Liabilities |
||||||||||
Fair value as of January 1, 2021 |
$ |
$ |
$ |
|||||||||
Initial measurement on January 28th, 2021 |
||||||||||||
Change in valuation inputs or other assumptions |
( |
) |
( |
) |
( |
) | ||||||
Fair value as of March 31, 2021 |
$ |
$ |
$ |
|||||||||
Forward Purchase Agreement Derivative |
||||
Fair value as of January 1, 202 2 |
$ | |||
Change in valuation inputs or other assumptions |
||||
Fair value as of March 31, 2022 |
$ | |||
Forward Purchase Agreement Derivative |
||||
Fair value as of January 1, 2021 |
$ |
|||
Initial measurement on January 28th, 2021 |
||||
Change in valuation inputs or other assumptions |
||||
Fair value as of March 31, 2021 |
$ |
|||
* | Filed herewith. |
** | Furnished. |
HUDSON EXECUTIVE INVESTMENT CORP. II | ||||||
Date: May 16, 2022 | By: | /s/ Douglas G. Bergeron | ||||
Name: | Douglas G. Bergeron | |||||
Title: | Chief Executive Officer (Principal Executive Officer) | |||||
Date: May 16, 2022 | By: | /s/ Ira Mosberg | ||||
Name: | Ira Mosberg | |||||
Title: | Chief Financial Officer (Principal Financial and Accounting Officer) |